Quoin Pharmaceuticals Ltd. (QNRX) stock forecast and price target
Price $3.70 · data as of November 13, 2026
12-month price target
Average target$20.38
Upside / downside+450.7%
Analysts8
ConsensusStrong buy
Low $12.00Average $20.38High $35.00
Gold marker: average target · white marker: today’s price ($3.70)
Analyst ratings
Strong buy 1Buy 6Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-5.25 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-2.71 | +48.4% | $0 |
| Next quarter ends December 31, 2026 | $-1.10 | — | $0 |
| Quarter after ends March 31, 2027 | $-1.07 | +39.6% | $0 |
Consensus of the analysts covering Quoin Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Quoin Pharmaceuticals stock price target?
The average 12-month target from 8 analysts is $20.38, 450.7% above the current price of $3.70 Targets range from $12.00 to $35.00.
Is Quoin Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Quoin Pharmaceuticals expected to earn?
Analysts expect EPS of $-5.25 for the fiscal year ending December 31, 2026 and $-2.71 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.